Abstract:The brown seaweed, Sacchairna japonica , has been used in traditional Chinese medicine for over one thousand years. Oral administration of fucoidan or low molecular weight fucoidan (LMWF) from S. japonica could ameliorate kidney dysfunction in chronic kidney diseases and inhibit diabetic vascular complications. In many studies, LMWF was found to be more potent than fucoidan with high molecular weight. However, the pharmacokinetics of LMWF still remains unclear. The purpose of the research is to compare the pharmacokinetics of fucoidan with high molecular weight (136 kDa) with that low molecular weight (9.5 kDa) after oral administration to ICR mice. Since fucose is the main and representative monosaccharide of fucoidans, we evaluate the pharmacokinetics of fucoidan and LMWF by determining the fucose concentration in mice serum. Both fucoidan and LMWF were absorbed following oral administration. Fucoidan and LMWF were provided to mice by oral administration with 60 mg/kg and the maximum Concentration ( C max ) was found at 2.5 h (0.66±0.32 mg/L) for Fucoidan and 1.5 h (1.01±0.56 mg/L) for LMWF, respectively. It seems that LMWF had a higher area under the curve (AUC 0− t ) and was absorbed more quickly than fucoidan. The estimated bioavailability of LMWF was 28.3% in the mice treated with a single dose of 30 mg/kg. In addition, LMWF was found widely spreaded into different tissues following oral administration and the highest concentration was found in kidney at 19.93±7.02 µg/g. In this study, we first studied the pharmacokinetics of LMWF, in order to help to understand the function of LMWF. And our results shed light on the potential of development of drugs based on LMWF.

Study on Absorption Mechanism and Tissue Distribution of Fucoidan

Use of Fluorescein Isothiocyanate Isomer I to Study the Mechanism of Intestinal Absorption of Fucoidan Sulfate in Vivo and in Vitro

Pharmacokinetics of fucoidan and low molecular weight fucoidan from Saccharina japonica after oral administration to mice

Preparation of Different Molecular Weights of Sea Cucumber Fucoidan and Study on Their Absorptive Characteristics in Rats

Enhanced Cellular Uptake in an Electrostatically Interacting Fucoidan–L-Arginine Fiber Complex

Fucoidans from Pearsonothuria Graeffei Prevent Obesity by Regulating Intestinal Lipid Metabolism and Inflammation Related Signalling Pathways

Determination of Fucoidan in Rat Plasma by HPLC and Its Application in Pharmacokinetics

The structure property and endothelial protective activity of fucoidan from Laminaria japonica.

Extraction, purification, structural characterization and anti-hyperlipidemia activity of fucoidan from Laminaria digitata

Mesoporous silica nanoparticles with fluorescent and magnetic dual-imaging properties to deliver fucoidan

In vitro and in vivo immunomodulatory effects of fucoidan compound agents

Bioactivity of fucoidan extracted from Laminaria japonica using a novel procedure with high yield

Determination of the active transport of fucoidan derived from Okinawa Mozuku across the human intestinal Caco-2 cells as assessed by size-exclusion chromatography

Research progress on biological activity of fucoidan from Phaeophyta

Advances on Fucoidan

Study of antioxidant activities of fucoidan from Laminaria japonica

Application of Fucoidan in Caco-2 Model Establishment.

Research progress on biological activities of fucoidan

Fucoidan: Structure and Bioactivity

Regulatory Effect of Fucoidan Hydrolysates on Lipopolysaccharide-Induced Inflammation and Intestinal Barrier Dysfunction in Caco-2 and RAW264.7 Cells Co-Cultures

Structure-function relationship analysis of fucoidan from sea cucumber (<i>Holothuria tubulosa</i>) on ameliorating metabolic inflammation